Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder occurring in the elderly. It is widely accepted that the amyloid beta peptide (Aβ) aggregation and especially the oligomeric states rather than fibrils are involved in AD onset. We used infrared spectroscopy to provide structural information on the entire aggregation pathway of Aβ(1–40), starting from monomeric Aβ to the end of the process, fibrils. Our structural study suggests that conversion of oligomers into fibrils results from a transition from antiparallel to parallel β-sheet. These structural changes are described in terms of H-bonding rupture/formation, β-strands reorientation and β-sheet elongation. As antiparallel β-sheet structure is also observed for other amyloidogenic proteins forming oligomers, reorganization of the β-sheet implicating a reorientation of β-strands could be a generic mechanism determining the kinetics of protein misfolding. Elucidation of the process driving aggregation, including structural transitions, could be essential in a search for therapies inhibiting aggregation or disrupting aggregates.
Similar content being viewed by others
Abbreviations
- Aβ:
-
Amyloid-beta
- AD:
-
Alzheimer’s disease
- ADDLs:
-
Aβ-derived diffusible ligands
- AFM:
-
Atomic force microscopy
- ATR:
-
Attenuated total reflection
- DMSO:
-
Dimethylsulfoxide
- FTIR:
-
Fourier-transform infrared spectroscopy
- TBS:
-
Tris-buffered saline solution
- ThT:
-
Thioflavin T
References
Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81:678–699
Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486–489
Vigo-Pelfrey C, Lee D, Keim P, Lieberburg I, Schenk DB (1993) Characterization of beta-amyloid peptide from human cerebrospinal fluid. J Neurochem 61:1965–1968
Wilquet V, De Strooper B (2004) Amyloid-beta precursor protein processing in neurodegeneration. Curr Opin Neurobiol 14:582–588
Xu Y, Shen J, Luo X, Zhu W, Chen K, Ma J, Jiang H (2005) Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci USA 102:5403–5407
Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373–379
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat Med 14:837–842
Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352–357
Kayed R, Pensalfini A, Margol L, Sokolov Y, Sarsoza F, Head E, Hall J, Glabe C (2009) Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer. J Biol Chem 284:4230–4237
Hardy JA, Higgins GA (1992) Alzheimer’s disease: the amyloid cascade hypothesis. Science 256:184–185
De Felice FG, Wu D, Lambert MP, Fernandez SJ, Velasco PT, Lacor PN, Bigio EH, Jerecic J, Acton PJ, Shughrue PJ, Chen-Dodson E, Kinney GG, Klein WL (2008) Alzheimer’s disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol Aging 29:1334–1347
De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL (2007) Abeta oligomers induce neuronal oxidative stress through an N-methyl-d-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 282:11590–11601
Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, Trommer BL (2002) Soluble oligomers of beta amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133–140
Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448–6453
Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer’s disease. J Neurosci 27:796–807
Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356
Ahmed M, Davis J, Aucoin D, Sato T, Ahuja S, Aimoto S, Elliott JI, Van Nostrand WE, Smith SO (2010) Structural conversion of neurotoxic amyloid-beta(1–42) oligomers to fibrils. Nat Struct Mol Biol 17:561–567
Yu L, Edalji R, Harlan JE, Holzman TF, Lopez AP, Labkovsky B, Hillen H, Barghorn S, Ebert U, Richardson PL, Miesbauer L, Solomon L, Bartley D, Walter K, Johnson RW, Hajduk PJ, Olejniczak ET (2009) Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry 48:1870–1877
Habicht G, Haupt C, Friedrich RP, Hortschansky P, Sachse C, Meinhardt J, Wieligmann K, Gellermann GP, Brodhun M, Gotz J, Halbhuber KJ, Rocken C, Horn U, Fandrich M (2007) Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils. Proc Natl Acad Sci USA 104:19232–19237
Cerf E, Sarroukh R, Tamamizu-Kato S, Breydo L, Derclaye S, Dufrene YF, Narayanaswami V, Goormaghtigh E, Ruysschaert JM, Raussens V (2009) Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide. Biochem J 421:415–423
Eckert A, Hauptmann S, Scherping I, Meinhardt J, Rhein V, Drose S, Brandt U, Fandrich M, Muller WE, Gotz J (2008) Oligomeric and fibrillar species of beta-amyloid (Aβ 42) both impair mitochondrial function in P301L tau transgenic mice. J Mol Med 86:1255–1267
Come JH, Fraser PE, Lansbury PT Jr (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90:5959–5963
Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282:10311–10324
Wetzel R (2006) Kinetics and thermodynamics of amyloid fibril assembly. Acc Chem Res 39:671–679
Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, Tycko R (2002) A structural model for Alzheimer’s beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99:16742–16747
Balbach JJ, Petkova AT, Oyler NA, Antzutkin ON, Gordon DJ, Meredith SC, Tycko R (2002) Supramolecular structure in full-length Alzheimer’s beta-amyloid fibrils: evidence for a parallel beta-sheet organization from solid-state nuclear magnetic resonance. Biophys J 83:1205–1216
Schmidt M, Sachse C, Richter W, Xu C, Fandrich M, Grigorieff N (2009) Comparison of Alzheimer Abeta(1–40) and Abeta(1–42) amyloid fibrils reveals similar protofilament structures. Proc Natl Acad Sci USA 106:19813–19818
Teplow DB, Lazo ND, Bitan G, Bernstein S, Wyttenbach T, Bowers MT, Baumketner A, Shea JE, Urbanc B, Cruz L, Borreguero J, Stanley HE (2006) Elucidating amyloid beta-protein folding and assembly: a multidisciplinary approach. Acc Chem Res 39:635–645
Chen D, Martin ZS, Soto C, Schein CH (2009) Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. Bioorg Med Chem 17:5189–5197
LeVine H III (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309:274–284
Goormaghtigh E, Raussens V, Ruysschaert JM (1999) Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes. Biochim Biophys Acta 1422:105–185
Goormaghtigh E, Cabiaux V, Ruysschaert JM (1990) Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem 193:409–420
Mastrangelo IA, Ahmed M, Sato T, Liu W, Wang C, Hough P, Smith SO (2006) High-resolution atomic force microscopy of soluble Abeta42 oligomers. J Mol Biol 358:106–119
Chirgadze YN, Nevskaya NA (1976) Infrared spectra and resonance interaction of amide-I vibration of the antiparallel-chain pleated sheet. Biopolymers 15:607–625
Krimm S, Bandekar J (1986) Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv Protein Chem 38:181–364
Miyazawa T, Blout ER (1961) The Infrared spectra of polypeptides in various conformations: amide I and II bands. J Am Chem Soc 83(3):712–719
Oberg KA, Ruysschaert JM, Goormaghtigh E (2004) The optimization of protein secondary structure determination with infrared and circular dichroism spectra. Eur J Biochem 271:2937–2948
Kubelka J, Keiderling TA (2001) Differentiation of beta-sheet-forming structures: ab initio-based simulations of IR absorption and vibrational CD for model peptide and protein beta-sheets. J Am Chem Soc 123:12048–12058
Zandomeneghi G, Krebs MR, McCammon MG, Fandrich M (2004) FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils. Protein Sci 13:3314–3321
Hoyer W, Gronwall C, Jonsson A, Stahl S, Hard T (2008) Stabilization of a beta-hairpin in monomeric Alzheimer’s amyloid-beta peptide inhibits amyloid formation. Proc Natl Acad Sci USA 105:5099–5104
Petkova AT, Yau WM, Tycko R (2006) Experimental constraints on quaternary structure in Alzheimer’s beta-amyloid fibrils. Biochemistry 45:498–512
Bitan G, Fradinger EA, Spring SM, Teplow DB (2005) Neurotoxic protein oligomers—what you see is not always what you get. Amyloid 12:88–95
Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini R, Tancredi T, Temussi PA, Picone D (2006) The alpha-to-beta conformational transition of Alzheimer’s Abeta-(1–42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 7:257–267
Fraser PE, Nguyen JT, Surewicz WK, Kirschner DA (1991) pH-dependent structural transitions of Alzheimer amyloid peptides. Biophys J 60:1190–1201
Peralvarez-Marin A, Mateos L, Zhang C, Singh S, Cedazo-Minguez A, Visa N, Morozova-Roche L, Graslund A, Barth A (2009) Influence of residue 22 on the folding, aggregation profile, and toxicity of the Alzheimer’s amyloid beta peptide. Biophys J 97:277–285
Walsh DM, Selkoe DJ (2007) Aβ oligomers—a decade of discovery. J Neurochem 101:1172–1184
Dasilva KA, Shaw JE, McLaurin J (2009) Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention. Exp Neurol 223(2):311–321
Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, Tone P, Glabe CG (2007) Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry 46:8850–8860
Ferrao-Gonzales AD, Robbs BK, Moreau VH, Ferreira A, Juliano L, Valente AP, Almeida FC, Silva JL, Foguel D (2005) Controlling {beta}-amyloid oligomerization by the use of naphthalene sulfonates: trapping low molecular weight oligomeric species. J Biol Chem 280:34747–34754
Garzon-Rodriguez W, Sepulveda-Becerra M, Milton S, Glabe CG (1997) Soluble amyloid Abeta-(1–40) exists as a stable dimer at low concentrations. J Biol Chem 272:21037–21044
Liao MQ, Tzeng YJ, Chang LY, Huang HB, Lin TH, Chyan CL, Chen YC (2007) The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett 581:1161–1165
Khurana R, Fink AL (2000) Do parallel beta-helix proteins have a unique fourier transform infrared spectrum? Biophys J 78:994–1000
Fabian H, Gast K, Laue M, Misselwitz R, Uchanska-Ziegler B, Ziegler A, Naumann D (2008) Early stages of misfolding and association of beta2-microglobulin: insights from infrared spectroscopy and dynamic light scattering. Biochemistry 47:6895–6906
Natalello A, Prokorov VV, Tagliavini F, Morbin M, Forloni G, Beeg M, Manzoni C, Colombo L, Gobbi M, Salmona M, Doglia SM (2008) Conformational plasticity of the Gerstmann–Straussler–Scheinker disease peptide as indicated by its multiple aggregation pathways. J Mol Biol 381:1349–1361
Lim YA, Rhein V, Baysang G, Meier F, Poljak A, Raftery MJ, Guilhaus M, Ittner LM, Eckert A, Gotz J (2010) Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 10:1621–1633
Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507–511
Ravault S, Soubias O, Saurel O, Thomas A, Brasseur R, Milon A (2005) Fusogenic Alzheimer’s peptide fragment Abeta (29–42) in interaction with lipid bilayers: secondary structure, dynamics, and specific interaction with phosphatidyl ethanolamine polar heads as revealed by solid-state NMR. Protein Sci 14:1181–1189
Acknowledgments
R.S. is Research Fellow for the Fund for Research in the Industry and Agriculture (Belgium), E.C. is Research Fellow for the National Fund for Scientific Research (Belgium), Y.F.D. and V.R. are Senior Research Associate and E.G. is Research Director for the National Fund for Scientific Research (Belgium). We thank Dr. C. Glabe for kindly providing A11 antibody, Dr. P. Boussard and Dr. Y. Looze for access to the fluorimeter.
Author information
Authors and Affiliations
Corresponding author
Additional information
R. Sarroukh and E. Cerf have equally contributed to this work.
Rights and permissions
About this article
Cite this article
Sarroukh, R., Cerf, E., Derclaye, S. et al. Transformation of amyloid β(1–40) oligomers into fibrils is characterized by a major change in secondary structure. Cell. Mol. Life Sci. 68, 1429–1438 (2011). https://doi.org/10.1007/s00018-010-0529-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-010-0529-x